HEALTHDAILY MAIL
Thousands with liver disease set to be prescribed weight-loss jab Wegovy, UK drugs watchdog announces
The UK drugs watchdog has announced that thousands of people with liver disease will be prescribed the weight-loss medication Wegovy. The decision aims to address the condition through a treatment that reduces weight, which is linked to liver health.
Related Signal
Adjacent reporting
- New drug could finally stop deadly fatty liver disease
- Illegal use of 'Reta' weight-loss drug is a 'huge, unregulated human experiment', warn doctors - as jab is linked to liver damage
- Illegal use of 'Reta' weight-loss drug is a 'huge, unregulated human experiment', warn doctors - as jab is linked to liver damage
- STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and more
- A new Medicare option for weight loss drugs is coming: Here's what to know
- Research shows weight-loss drugs may also reduce cancer risk